CARDENSIEL

This brand name is authorized in France, Tunisia

Active ingredients

The drug CARDENSIEL contains one active pharmaceutical ingredient (API):

1 Bisoprolol
UNII UR59KN573L - BISOPROLOL FUMARATE

Bisoprolol is a potent highly beta1-selective-adrenoceptor blocking agent, lacking intrinsic stimulating and without relevant membrane stabilising activity.

Read about Bisoprolol

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code Group title Classification
C07AB07 Bisoprolol C Cardiovascular system → C07 Beta blocking agents → C07A Beta blocking agents → C07AB Beta blocking agents, selective
Discover more medicines within C07AB07

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country Identification scheme Identifier(s)
Country: FR Base de donnรฉes publique des mรฉdicaments Identifier(s): 60077574, 61804539, 63162282, 66279248, 66351548, 69269647
Country: TN Direction de la Pharmacie et du Mรฉdicament Identifier(s): 3183051, 3183052, 3183053

ยฉ All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.